Regen robot for assisting treadmill walking in healthy adults
Official title: Usability of the Regen Gait Therapy Robot in Healthy Adults
Run by University of Texas at Austin · NCT07547683 · Data updated 2026-11-12
We will test whether the Regen gait robot is safe, easy to use, and can copy a therapist's walking movements in healthy adults walking on a treadmill.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Status | Recruiting |
| Started | March 26, 2026 |
| Main results expected | May 1, 2026 |
| Study ends | June 1, 2026 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT07547683 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy adults aged 18–50 who can walk on a treadmill for at least six minutes, along with licensed physical therapists experienced in gait rehabilitation to operate the device.
✕Probably not a fit
People with neurological or orthopedic conditions affecting walking, recent lower-limb surgery, current lower-limb pain, balance-impairing medications, open lower-limb wounds, or inability to walk six minutes are unlikely to be eligible or to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project tests a robot-assisted device designed to replicate a therapist's lower-limb guidance during treadmill gait training. Healthy adults (ages 18–50) who can walk independently and licensed physical therapists with gait-rehab experience will take part in supervised treadmill sessions using the Regen device. The study will track safety events, feasibility of operation, usability via standardized questionnaires, and compare the robot's movement patterns to those produced by therapists using motion data. Findings will determine whether the device can reliably reproduce therapist motions and be used safely in clinical settings.
Why it matters
Potential benefit: If successful, the Regen robot could reduce therapist physical strain and enable more consistent, higher-dose gait practice for patients, potentially improving rehabilitation outcomes.
How similar studies have gone: Previous robotic gait-training devices have shown promise in delivering repeatable assisted practice and improving some rehabilitation outcomes, but many devices differ in function and the Regen's therapist-mimicking approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Healthy study participants: adults (18-50 years) who can walk independently on a treadmill for at least 6 minutes 2. Physical therapist (PT) with a license and experience in gait rehab (self-reported) Exclusion Criteria: (1) For healthy study participants: 1. Any neurological or orthopedic condition that can affect walking (Self-reported) 2. Uncontrolled cardiovascular or metabolic condition that can affect walking (Self-reported) 3. Current lower-limb pain or discomfort 4. Lower-limb surgery within the past six months 5. On medications that may impair balance (Self-reported) 6. Open wound in the lower limb (2) For PT: 1. Not having license 2. No experience in gait rehab
Where it's running
-
University of Texas at Austin
Austin, Texas, United States Recruiting
Study contacts
- Principal investigator: Hao-Yuan Hsiao, PhD — University of Austin at Texas
- Study coordinator: Mac Prible, PhD
- Email: prible@utexas.edu
- Phone: 6466208829
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.